Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

132 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
B cell depletion may be more effective than switching to an alternative anti-tumor necrosis factor agent in rheumatoid arthritis patients with inadequate response to anti-tumor necrosis factor agents.
Finckh A, Ciurea A, Brulhart L, Kyburz D, Möller B, Dehler S, Revaz S, Dudler J, Gabay C; Physicians of the Swiss Clinical Quality Management Program for Rheumatoid Arthritis. Finckh A, et al. Among authors: kyburz d. Arthritis Rheum. 2007 May;56(5):1417-23. doi: 10.1002/art.22520. Arthritis Rheum. 2007. PMID: 17469098 Free article.
Tolerance and effectiveness of anti-tumor necrosis factor alpha therapies in elderly patients with rheumatoid arthritis: a population-based cohort study.
Genevay S, Finckh A, Ciurea A, Chamot AM, Kyburz D, Gabay C; Physicians of the Swiss Clinical Quality Management Program for Rheumatoid Arthritis. Genevay S, et al. Among authors: kyburz d. Arthritis Rheum. 2007 May 15;57(4):679-85. doi: 10.1002/art.22688. Arthritis Rheum. 2007. PMID: 17471545 Free article.
Which subgroup of patients with rheumatoid arthritis benefits from switching to rituximab versus alternative anti-tumour necrosis factor (TNF) agents after previous failure of an anti-TNF agent?
Finckh A, Ciurea A, Brulhart L, Möller B, Walker UA, Courvoisier D, Kyburz D, Dudler J, Gabay C; Arthritis. Finckh A, et al. Among authors: kyburz d. Ann Rheum Dis. 2010 Feb;69(2):387-93. doi: 10.1136/ard.2008.105064. Epub 2009 May 4. Ann Rheum Dis. 2010. PMID: 19416802 Free PMC article.
Evolution of radiographic joint damage in rituximab-treated versus TNF-treated rheumatoid arthritis cases with inadequate response to TNF antagonists.
Finckh A, Möller B, Dudler J, Walker UA, Kyburz D, Gabay C; physicians of the Swiss Clinical Quality Management for Rheumatoid Arthritis; physicians of SCQM-RA. Finckh A, et al. Among authors: kyburz d. Ann Rheum Dis. 2012 Oct;71(10):1680-5. doi: 10.1136/annrheumdis-2011-201016. Epub 2012 Mar 14. Ann Rheum Dis. 2012. PMID: 22419773 Free PMC article.
Use of abatacept in rheumatoid arthritis.
von Kempis J, Dudler J, Hasler P, Kyburz D, Tyndall A, Zufferey P, Villiger PM. von Kempis J, et al. Among authors: kyburz d. Swiss Med Wkly. 2012 May 11;142:w13581. doi: 10.4414/smw.2012.13581. eCollection 2012. Swiss Med Wkly. 2012. PMID: 22581564 Free article. Review.
132 results